Nick DeVito and Ben Goldacre Background The US FDA Amendments Act (FDAAA 2007) requires certain clinical trials to report their results onto ClinicalTrials.gov within one year of completion. Our FDAAA […]
Latest articles
Embedding public and patient involvement in research
A researcher, patient advisor and patient reviewer describe how they included patient input in a trial from the start right through to publication […]
Mary Dallat: Retaining the UK’s close bilateral working relationship with the European Centre for Disease Prevention and Control
As the UK plans for a post-Brexit state, careful consideration of current health security provisions is needed to protect and enhance the public’s health across the UK and EU. Infectious […]
Terence Stephenson on the Williams review—the chance to make our health system the safest and best must not be missed
It is a huge disappointment that the review has failed to seize the opportunity to protect doctors’ reflections in law […]
Clinical study reports should be available to help clinicians and patients make informed decisions
The merits of publicly releasing study protocols and statistical analysis plans have been overlooked in the vigorous debate about releasing individual participant level data. [1] In this Opinion, we argue that […]
Sam Finnikin: NICE move to improve the quality of shared decision making
On the 7th of June, the National Institute for Health and Care Excellence (NICE) hosted its fifth collaborative on shared decision making in London. NICE’s main business is the production […]
Richard Lehman’s journal review—11 June 2018
Richard Lehman reviews the latest research in the top medical journals […]
Jeffrey Aronson: When I use a word . . . The geniousness of Doug Altman
As the whole world knows, Doug Altman died this week. The news provoked a Twitter storm of large proportions, over 200 messages in five days, plus innumerable retweets. The significant […]
Wendy Burn: Being bipolar can be “awesome” . . . but only if you get the right support
Kanye West’s revelation that he has bipolar disorder is a strike against stigma. Yet raising awareness is not enough […]
Protecting the accuracy of clinical trial data in China
The Chinese government has signalled its commitment to ensuring the quality of clinical trials conducted in China. In 2015, the China Food and Drug Administration (CFDA) announced a plan to […]